Lotte Fine Chemical Co., South Korea’s largest ammonia producer, will spend a total of 129 billion won ($99 million) in an aim to become the world’s largest food and pharmaceutical materials producer and bump up its green materials sales by six times by 2030 to outdistance Chinese rivals.
The subsidiary of Lotte Chemical Corp. said on Thursday that its board of directors late last month approved a new plan to inject 79 billion won to jack up the production capacity of cellulose ethers widely used in manufacturing foods and pharmaceutical drugs to 6,000 tons a year.
The company originally planned to invest 39 billion won to expand the capacity to 3,000 tons.
Once the addition of new cellulose derivative production lines is completed by 2025 under the new plan, the Korean fine chemical company will boast the world’s largest production capacity of food and pharmaceutical chemical materials.
The US-based International Flavors & Fragrances Inc. (IFF) is currently the world’s No. 1 in the market, followed by Lotte Fine Chemical and Japan’s Shin-Etsu Chemical Co.
(Graphics by Sunny Park) Lotte Fine Chemical has chosen specialty green chemical materials such as cellulose ethers as one of its key growth drivers as the sector bars latecomers from entering with high barriers.
However, they have not yet obtained the technology to produce specialty chemicals like green materials.
To further distance itself from Chinese rivals, Lotte Fine Chemical will also inject 50 billion won to build up its research and development capabilities in the green materials sector.
It plans to expand the number of its R&D researchers and scientists to 300 in 2030 from the current 62 to increase its green materials sales to 3 trillion won in 2030 from 492.8 billion won in 2022.
CELLULOSE ETHERS AS A KEY GROWTH DRIVER
Lotte Fine Chemical produces cellulose ethers that can be used in manufacturing foods and pharmaceutical drugs.
A researcher at Lotte Fine Chemical's R&D center in Seoul (Courtesy of Lotte Fine Chemical) AnyAddy is its cellulose derivative used in food, food supplements and personal care to improve texture.
AnyCoat is its brand for cellulose ethers as an inactive drug ingredient used to enhance the sustained release of medicines. It is coated on tablets or capsules to slow the release of medical substances at a programmed rate to deliver the drug over a prolonged period to extend therapy efficacy.
Lotte Fine Chemical pins high hopes on cellulose ethers, demand for which is set to grow rapidly.
As the world's population is aging quickly and demand for capsule and tablet pills is rising fast, the inactive pharmaceutical ingredient market is forecast to grow to $12.2 billion in 2028 from $7.8 billion in 2022, according to Research and Markets.
In addition, biotech startups, which generally spend an astronomical amount of capital to develop novel drugs and several years of clinical trials to prove their efficacy and safety, rarely change inactive drug ingredients once they make a final decision, said Kang Gyung-don, the head of a research strategy team at Lotte Fine Chemical.
The Korean company is currently seeking to collaborate with a promising biotech startup to research and form a joint venture to develop such ingredients, while reviewing a merger and acquisition.
It also plans to work with biotech startups to advance into the generic medicine market with patent-expiring drugs, the company said.
Write to Hyung-Kyu Kim at khk@hankyung.com Sookyung Seo edited this article.
